Syngenta Flags $6 Billion R&D Pipeline to Deflated Investors

Updated on
  • Crop protection products have $3.6 billion sales potential
  • Revenue from seeds and traits set to more than double

Syngenta AG, which rebuffed a $47 billion bid from Monsanto Co., said it’s accelerating the pace of innovation and has a pipeline of new technology with combined sales potential of more than $6 billion as the agrochemical supplier looks to build investor confidence in its go-it-alone strategy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.